Zhang, Kai-Liang <br/><br/>
Blockage of a miR-21/EGFR regulatory feedback loop augments anti-EGFR therapy in glioblastomas.  [electronic resource] 

 -  Cancer letters  Jan 2014 
 - 139-49 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1872-7980 
<br/><br/><label>Standard No.: </label>10.1016/j.canlet.2013.08.043  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>3' Untranslated Regions<br/>Animals<br/>Antibodies, Monoclonal, Humanized--pharmacology<br/>Antineoplastic Agents--pharmacology<br/>Base Sequence<br/>Binding Sites<br/>Brain Neoplasms--drug therapy<br/>Cell Line, Tumor<br/>ErbB Receptors--antagonists & inhibitors<br/>Feedback, Physiological<br/>Gene Expression Regulation, Neoplastic<br/>Glioblastoma--drug therapy<br/>Humans<br/>Mice<br/>Mice, Nude<br/>MicroRNAs--genetics<br/>Neoplasm Invasiveness<br/>PPAR alpha--genetics<br/>Proto-Oncogene Proteins c-akt--metabolism<br/>RNA Interference<br/>Transcription Factor AP-1--metabolism<br/>Tumor Burden<br/>Von Hippel-Lindau Tumor Suppressor Protein--metabolism<br/>Wnt Signaling Pathway<br/>Xenograft Model Antitumor Assays<br/>beta Catenin--metabolism